Citation 153921

DOLAK,LA: DEBOER,C:. (1980). CLAZAMYCIN B IS ANTIBIOTIC 354.. 33()

Year: 1980

Journal: Unknown

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	ISOLATION AND IDENTIFICATION OFPHARMACOLOGY OF COMPOUND - IN VIVO	CLAZAMYCIN B	.
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CLAZAMYCIN B	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE
7	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE
8	TOXIC EFFECT(GENERAL)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CLAZAMYCIN B	ACTIVE